HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks

HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks

Pablo Mandó,1 Federico Waisberg,2 Rosario Pasquinelli,1 Sergio Rivero,2 Alexis Ostinelli,2 Florencia Perazzo1 1Clinical Oncology Department, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC), Ciudad Autónoma de Buenos Aires, Argentina; 2Clinical Oncology Department, Ins...

Full description

Bibliographic Details
Main Authors: Mandó P, Waisberg F, Pasquinelli R, Rivero S, Ostinelli A, Perazzo F
Format: Article
Language:English
Published: Dove Medical Press 2023-02-01
Series:OncoTargets and Therapy
Subjects:
breast cancer – her2 – monoclonal antibodies – tyrosine kinase inhibitors – antibody drug conjugates
Online Access:https://www.dovepress.com/her2-directed-therapy-in-advanced-breast-cancer-benefits-and-risks-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/her2-directed-therapy-in-advanced-breast-cancer-benefits-and-risks-peer-reviewed-fulltext-article-OTT

Similar Items